Mucinous Colorectal Adenocarcinoma with Signet-Ring Cells: Immunohistochemical and Ultrastructural Study

REFERENCES

• Hamilton SR, Vogelstein B, Kudo S, et al., eds. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2000:103–143.
   Google Scholar
• Wolfman EF Jr, Astler VB, Coller FA. Mucoid adenocarcinoma of the colon and rectum. Surgery. 1957;42:846–852.
   PubMedGoogle Scholar
• Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM. Signet-ring cell carcinoma of the colon and rectum a matced control study. Dis Colon Rectum. 1999;42:1176–1180.
   PubMedGoogle Scholar
• Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48:1161–1168.
   PubMed Web of Science ®Google Scholar
• Umpleby HC, Ranson DL, Williamson RC. Peculiarities of mucinous colorectal carcinoma. Br J Surg. 1985;72:715–718.
   PubMedGoogle Scholar
• Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol. 1988;41:1068–1072.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Mochizuki H, Hase K, et al. Assessment of clinicopathoogic features of colorectal mucinous adenocarcinoma. Am J Surg. 1993;166:257–256.
   PubMed Web of Science ®Google Scholar
• Messerini S, Palomba A, Zambi G. Primary signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 1995;38:1189–1192.
   PubMedGoogle Scholar
• Anthony T, George R, Rodriguez-Bigas M, Petrelli NJ. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol. 1996;3:344–348.
   PubMedGoogle Scholar
• Tung SY, Wu CS, Chen PC. Primary signet-ring cell carcinoma of colorectum: an age and sex-matched controlled study. Am J Gastroenterol. 1996;91:2195–2199.
   PubMedGoogle Scholar
• Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM. Signet ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum. 1999;42:1176–1180.
   PubMedGoogle Scholar
• Ooi BS, Ho YH, Eu KW, Seow Choen F. Primary colorectal signet-ring cell carcinoma in Singapore. ANZ J Surg. 2001;71:703–706.
   PubMedGoogle Scholar
• Holmang S, Borghede G, Johanson SL. Primary signet ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol. 1997;31:145–148.
   PubMed Web of Science ®Google Scholar
• Smith C, Feddersen RM, Dressler L, McConnell T, Milroy T, Smith AY. Signet ring cell adenocarcinoma of the prostate. Urology. 1994;43:397–400.
   PubMedGoogle Scholar
• McArthur CP, Fiorella R, Saran BM. Rare primary signet ring carcinoma of the pancreas. Mol Med. 1995;92:298–302.
   Google Scholar
• Eltorky M, Hall JC, Osborne PT, el Zeky F. Signet-ring cell variant of invasive lobular carcinoma of the breast: a clinicopathologic study of cases. Arch Pathol Lab Med. 1994;118:245–248.
   PubMedGoogle Scholar
• Kish JK, Ro JY, Ayala AG, et al. Primary mucinous adenocarcinoma of the lung with signet-ring cells. Hum Pathol. 1989;20:1097–1102.
   PubMedGoogle Scholar
• Maehara Y, Sakaguchi Y, Moriguchi S, et al. Signet ring cell carcinoma of the stomach. Cancer. 1992;69:1645–1650.
   PubMed Web of Science ®Google Scholar
• Laufman H, Saphir O. Primary linitis plastica type of carcinoma of the colon. AMA Arch Surg. 1951;62:79–91.
   PubMedGoogle Scholar
• Tandon M, Sostek M, Klein M. Focus of signet ring cell carcinoma in an adenoma of the sigmoid colon. Arch Pathol Lab Med. 1999;123:957–959.
   PubMedGoogle Scholar
• Wasaki W, Masaki T, Umetani N, Futakawa N, Ando H, Muto T. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn J Clin Oncol. 1998;28:202–206.
   PubMedGoogle Scholar
• Ponz de Leon M, Di Gregorio C. Pathology of colorectal cancer. Dig Liver Dis. 2001;33:372–388.
   PubMedGoogle Scholar
• Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology. 1994;51:30–34.
   PubMed Web of Science ®Google Scholar
• Bittorf B, Merkel S, Matzel K, Wein A, Dimmler A, Hohenberger W. Primary signet-ring cell carcinoma of the colorectum. Langenbeck's Arch Surg. 2004;389(3):178–183.
   PubMedGoogle Scholar
• Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study in an Asian country. Dis Colon Rectum. 2004;47:78–85.
   PubMedGoogle Scholar
• Wu Cs, Tung SY, Chen PC, Kuo YC. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol. 1996;11:77–81.
   PubMedGoogle Scholar
• Kanemitsu Y, Kato T, Hirai T, et al. Survival after curative resection for mucinous adenocarcinoma of colorectum. Dis Colon Rectum. 2003;46:160–167.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. 2000;75:103–107.
   PubMed Web of Science ®Google Scholar
• Pande R, Sunga A, Levea C, et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum. 2008;51:50–55.
   PubMed Web of Science ®Google Scholar
• Ogino S, Brahmandam M, Cantor M, et al. Dinstict molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006;19:59–68.
   PubMed Web of Science ®Google Scholar
• Borger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212(3):278–286.
   PubMedGoogle Scholar
• Wistuba II, Behrens C, Albores-Saaverda J, Delgado R, Lopez F, Gazdar A. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clin Cancer Res. 2003;9:3615–3619.
   PubMedGoogle Scholar
• Bakkelund K, Fossmark R, Nordrum I, Waldum H. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J Histol Cytol. 2006;54:615–621.
   PubMed Web of Science ®Google Scholar
• Brouland JP, Manivet P, Brocheriou-Spelle I, et al. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2b receptor by the neuroendocrine component. Endo Pathol. 2001;12:77–86.
   PubMedGoogle Scholar
• Nugent SL, Cunningham SC, Alexiev BA, Bellavance E, Papadimitriou JC, Hanna N. Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity. Diagn Pathol. 2007;2:43.
   PubMedGoogle Scholar
• Seretis EC, Agnantis NJ, Golematis VC, Voloudakis- Balatzis IE. Electron immunocytochemical demonstration of serotonin, vasoactive intestinal polypeptide, bombesin, somatostatin and glucagon in mirror biopsies from primary colorectal adenocarcinomas. J Exp Clin Cancer Res. 2004;23:477–484.
   PubMedGoogle Scholar
• Seretis E, Gavriil A, Agnantis N, Golematis V, Voloudakis-Baltatzis IE. Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon. Ultrastruct Pathol. 2001;25:445–454.
   PubMed Web of Science ®Google Scholar
• Sereti E, Gavriil A, Agnantis N, Golematis VC, Voloudakis-Baltatzis IE. Immunoelectron study of somatostatin, gastrin and glucagon in human colorectal adenocarcinomas and liver metastases. Anticancer Res. 2002;22:2117–2123.
   PubMedGoogle Scholar